Contact Us Support

Kastango Consulting Group – Meet the Team

Mary Nazzal, PharmD, BSCSP

Mary Nazzal, a PharmD, Registered Pharmacist, is the Director of Field Operations for KCG.

She received her PharmD degree from Butler University of Indianapolis and has completed the Nuclear Pharmacy Certificate Program at Purdue University. Mary received her Compounded Sterile Preparations Certification from the Board of Pharmacy Specialties in the fall of 2019 as a member of its inaugural class.

She has over 14 years of progressive and diverse hospital pharmacist experience, including administrative, inpatient pharmacy, de-centralized pharmacy, and operating room with a focus in sterile compounding. Before joining KCG in 2017, Mary established and led sterile compounding services, including pharmacy-related policy/procedure/SOP development, technology setup and implementation, training development, and execution for Cleveland Clinic, Abu Dhabi in the United Arab Emirates. She performs gap analysis, facility design development, and review of construction documents for clients to ensure regulatory compliance as well as provide best practice recommendations regarding sterile compounding. She is also a member of the American Society of Health-System Pharmacists (ASHP) and Indiana Pharmacists Association.

Mark Bodnar, RPh

Mark Bodnar, BS Pharm, Registered Pharmacist, Rutgers University alumni is Director of Special Projects for KCG, with over 40 years’ experience in sterile compounding: hospital, infusion therapy/home, and LTC as well as FDA-regulated outsourcing facilities.

Mark’s focus through the years has been the introduction and installation of GCP/GMP culture through quality systems management of SOP development, documentation, training, and CAPA. Mark performs construction document reviews to ensure regulatory compliance and recommends best practices for sterile compounding. He is also a peer reviewer for gap analysis, facility design development, and other related documents. Mark is likewise a Rutgers University preceptor for IPPE and APPE pharmacy students during their rotation cycles and is involved with various medical device studies related to sterile compounding.



Kimberly Coughlin, B.S., RCP-SCF, NSF-49

Kimberly currently serves as the Director of Microbiology for KCG, joining in early 2019.

In her role, she provides consultation on environmental monitoring, remediation, and facility design performance. Kimberly is also responsible for reviewing regulatory compliance and performing onsite gap analysis at client facilities and audits of client vendors.

Kimberly has over 20 years of experience in microbiology laboratory testing, environmental monitoring, field testing, and certification of engineering controls in the pharmaceutical, medical device, research, and sterile compounding industries. During Kimberly’s industry tenure, she has worked with clients to develop meaningful environmental monitoring programs and successful remediation plans and has consulted on remedial efforts for engineering control performance issues.

Since 2015, Kimberly has served as a Director on the Controlled Environment Testing Association (CETA) Board of Directors. She is the 2019–2021 President-elect for CETA and Program Chair for the 2020 and 2021 annual meetings. Kimberly also serves as a subject matter expert (SME) for the CETA National Board of Testing’s (CNBT) Registered Certification Professional — Sterile Compounding Facilities (RCP-SCF) accreditation program. She served as the past Chair/Board Liaison of the CBNT Executive Committee and continues to serve as a committee member. She held a lead role in the writing of ISPE’s Good Practice Guide: HVAC and Process Equipment Air Filters. Kimberly received her Bachelor of Science degree in Environmental Science from Westfield State College. She received NSF Accreditation for the Field Certification of Class II Biosafety Cabinets and CETA accreditation as a Registered Certification Professional — Sterile Compounding Facilities.


Adam West, RCP-SCF, NSF-49

Adam West is the Environmental Monitoring and Training Specialist at CriticalPoint, LLC, a health-care training and development company.

In his current role, he is responsible for the development and delivery of live face-to-face, virtual, and eLesson curriculum related to aspects of primary and secondary engineering controls and certification. He also works with KCG, providing consulting for environmental monitoring investigations and remediation, facility design, and certification of primary and secondary engineering controls for sterile compounding facilities.

Adam has over ten years of experience in the certification industry providing Field Certification Services for 503A and 503B sterile compounding facilities and pharmaceutical and medical device manufacturers. In addition to certification, he has extensive knowledge in viable environmental monitoring, including sampling plan development and remediation, and has provided consultation services for USP Chapter 797 and 800 facility design compliance. Adam holds the Registered Certification Professional – Sterile Compounding Facilities (RCP-SCF) certification and NSF-49 accreditation.


Eric Kastango, M.B.A., B.S.Pharm., FASHP

Eric S. Kastango, M.B.A., B.S.Pharm., FASHP, is a consultant of Kastango Consulting Group, a health care consulting firm.

Mr. Kastango received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. He completed 65 hours of training in nuclear pharmacy at Purdue University and 80 hours of didactic training for the Six Sigma-Green Belt certification that he started with BD Medical Systems.

Eric received a coveted ISMP Cheers Award in 2015 for his work related to sterile compounding safety.  He is one of four recipients of the 2013 Outstanding Service Award from the Massachusetts Society of Health-System Pharmacists and the 2014 recipient of the NABP Henry Cade Memorial Award that recognized his efforts and assistance to the states and NABP to address the compounding tragedy that occurred in 2012.

Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation. He has also managed a FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation.

He is an active member and Fellow of the American Society of Healthcare Pharmacists and served on the USP Sterile Compounding Committee from 2005-2010 and 2010-2015 USP Council of Experts, Compounding Expert Committee until April 2013. In May 2013, USP recognized Eric and the members of Compounding Expert Committee with an Award for Outstanding Contribution to the USP Standards-Setting Process.

He has served on the USP Hazardous Drug Expert Panel since 2010. He is actively working with NABP and state boards of pharmacy to provide training to their sterile compounding inspectors.  Eric served on the Expert Panel for ASHP Research & Education Foundation in the development of the 2015 Outsourcing Sterile Products Preparation Vendor Assessment Tool and ASHP’s Insourcing Readiness Assessment Tool.

He is also the author of the 2004 ASHP Discussion Guide on Sterile Preparation: Summary and Implementation of USP Chapter 797, the ASHP Sterile Product Preparation CD-ROM: A Multimedia Learning Tool, the ASHP web-based 797 Compliance Advisor Gap Analysis Tool for USP Chapter 797. He assisted in the development of the CriticalPoint web-based educational series on Sterile Compounding and the Annual National USP <797> Compliance Survey now in its fifth year.  Eric has over 200 invited national and international professional presentations on various pharmacy practice topics such as pharmacy compounding, patient safety and quality systems.